Genmab A/S (CPH: GMAB)
1,873.50
-4.00 (-0.21%)
Aug 30, 2024, 4:59 PM CET
Genmab Market Cap
Genmab has a market cap or net worth of 118.96 billion as of August 30, 2024. Its market cap has decreased by -26.64% in one year.
Market Cap
118.96B
Enterprise Value
104.24B
Revenue
19.02B
Ranking
n/a
PE Ratio
22.19
Stock Price
1,873.50
Market Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 3.68B to 118.96B, an increase of 3,128.82%. That is a compound annual growth rate of 15.66%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Novo Nordisk A/S | 4,000.40B |
Coloplast A/S | 203.39B |
Demant A/S | 61.26B |
Zealand Pharma A/S | 61.04B |
H. Lundbeck A/S | 46.10B |
H. Lundbeck A/S | 46.10B |
ALK-Abelló A/S | 39.37B |
Ambu A/S | 38.76B |